Back

Arterial thromboembolism in patients with atrial fibrillation and CHA2DS2-VASc score 1: a nationwide study

25 August 2023 (15:15 - 15:50)
Organised by: Logo
Congress Presentation Part of: Risk factors and outcome in patients with atrial fibrillation Stroke in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Lauge Ostergaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Perioperative atrial fibrillation in relation to major emergency abdominal surgery and non-perioperative new onset atrial fibrillation: is there a difference in outcome?
Mrs A. Tas (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation on mortality and non-fatal cardiovascular outcomes in 145 293 patients admitted with COVID-19: a statewide population-linkage study
Doctor J. Ne (Concord, AU)
Abstract Slides Video
Presentation thumbnail
Adverse outcomes according to metabolic status in obese and overweight patients with atrial fibrillation: a report from the GLORIA-AF Phase II and III Registry
Doctor B. Corica (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Coffee consumption and adverse outcome events in patients with atrial fibrillation
Mr V. Iten (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Trends in clinical outcomes of patients with incident atrial fibrillation; results from a nationwide registry
Doctor L. Henriques (Tel Aviv, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and outcome in patients with atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Incidence, management and outcomes of patients with incident atrial fibrillation in the contemporary direct oral anti coagulants era. A national study
thumbnail
Congress Presentation
Dynamic change in anticoagulation pattern at age 65 years in patients with atrial fibrillation and prior low thromboembolic risk.
thumbnail
Congress Presentation
Effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation. The NOAH-AFNET 6 trial.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources